<?xml version="1.0" encoding="UTF-8"?> <!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd"> <ArticleSet> <Article> <Journal> <PublisherName>isfcppharmaspire</PublisherName> <JournalTitle>Pharmaspire</JournalTitle> <PISSN>C</PISSN> <EISSN>o</EISSN> <Volume-Issue>Volume 14, Issue 04 , 2022 </Volume-Issue> <PartNumber/> <IssueTopic>Multidisciplinary</IssueTopic> <IssueLanguage>English</IssueLanguage> <Season>October-December </Season> <SpecialIssue>N</SpecialIssue> <SupplementaryIssue>N</SupplementaryIssue> <IssueOA>Y</IssueOA> <PubDate> <Year>-0001</Year> <Month>11</Month> <Day>30</Day> </PubDate> <ArticleType>Quality Assurance</ArticleType> <ArticleTitle>Lipid nanoparticles: An advanced delivery system for quercetin</ArticleTitle> <SubTitle/> <ArticleLanguage>English</ArticleLanguage> <ArticleOA>Y</ArticleOA> <FirstPage>130</FirstPage> <LastPage>134</LastPage> <AuthorList> <Author> <FirstName>Galal Mohsen Hussein</FirstName> <LastName>Alsayadi</LastName> <AuthorLanguage>English</AuthorLanguage> <Affiliation/> <CorrespondingAuthor>N</CorrespondingAuthor> <ORCID/> <FirstName>Junaid Ul</FirstName> <LastName>Hamid</LastName> <AuthorLanguage>English</AuthorLanguage> <Affiliation/> <CorrespondingAuthor>Y</CorrespondingAuthor> <ORCID/> <FirstName>Preeti</FirstName> <LastName>Patel</LastName> <AuthorLanguage>English</AuthorLanguage> <Affiliation/> <CorrespondingAuthor>Y</CorrespondingAuthor> <ORCID/> <FirstName>Balak Das</FirstName> <LastName>Kurmi</LastName> <AuthorLanguage>English</AuthorLanguage> <Affiliation/> <CorrespondingAuthor>Y</CorrespondingAuthor> <ORCID/> </Author> </AuthorList> <DOI>10.56933/Pharmaspire.2022.14217</DOI> <Abstract>Quercetin is a flavonoid with strong antioxidant activity considered as a potential drug candidate for number of chronic diseases; crude quercetin suffers from poor water solubility and consequently topical inactivity. Therefore, quercetin formulation within a suitable system that overcomes its solubility limitation is a matter of investigation. Many approaches were tested to improve quercetin delivery to skin. One effective approach is lipid nanocapsules. These nanoformulations are ideal in terms of average particle size and homogeneity (PDI). Hence, lipid nanoparticles are an attractive candidate for the encapsulation of quercetin for potent and effective drug delivery.</Abstract> <AbstractLanguage>English</AbstractLanguage> <Keywords>Antioxidant, Liposomes, Nanotechnology, Quercetin, Solid lipid nanoparticles</Keywords> <URLs> <Abstract>https://isfcppharmaspire.com/ubijournal-v1copy/journals/abstract.php?article_id=14353&title=Lipid nanoparticles: An advanced delivery system for quercetin</Abstract> </URLs> <References> <ReferencesarticleTitle>References</ReferencesarticleTitle> <ReferencesfirstPage>16</ReferencesfirstPage> <ReferenceslastPage>19</ReferenceslastPage> <References>1. Caddeo C, Gabriele M, Fernand;agrave;ndez-Busquets X, Valenti D, Fadda AM, Pucci L, et al. Antioxidant activity of quercetin in Eudragit-coated liposomes for intestinal delivery. Int J Pharm 2019;565:64-9. 2. Huang J, Wang Q, Chu L, Xia Q. Liposome-chitosan hydrogel bead delivery system for the encapsulation of linseed oil and quercetin: Preparation and in vitro characterization studies. LWT 2020;117:108615. 3. Seong JS, Yun ME, Park SN. Surfactant-stable and pH-sensitive liposomes coated with N-succinyl-chitosan and chitooligosaccharide for delivery of quercetin. Carbohydr Polym 2018;181:659-67. 4. Jeon S, Yoo CY, Park SN. Improved stability and skin permeability of sodium hyaluronate-chitosan multilayered liposomes by layer-by-layer electrostatic deposition for quercetin delivery. Colloids Surf B Biointerfaces 2015;129:7-14. 5. Yang F, Jin C, Jiang Y, Li J, Di Y, Ni Q, et al. Liposome based delivery systems in pancreatic cancer treatment: From bench to bedside. Cancer Treat Rev 2011;37:633-42. 6. Riaz MK, Zhang X, Wong KH, Chen H, Liu Q, Chen X, et al. Pulmonary delivery of transferrin receptors targeting peptide surface-functionalized liposomes augments the chemotherapeutic effect of quercetin in lung cancer therapy. Int J Nanomedicine 2019;14:2879-902. 7. Patel G, Thakur NS, Kushwah V, Patil MD, Nile SH, Jain S, et al. Liposomal delivery of mycophenolic acid with quercetin for improved breast cancer therapy in SD rats. Front Bioeng Biotechnol 2020;8:631. 8. Jiang M, Zhang E, Liang Z, Zhao Y, Zhang S, Xu H, et al. Liposome-based co-delivery of 7-O-geranyl-quercetin and IGF-1R siRNA for the synergistic treatment of non-small cell lung cancer. J Drug Deliv Sci Technol 2019;54:101316. 9. Rajpoot K, Jain SK. Oral delivery of pH-responsive alginate microbeads incorporating folic acid-grafted solid lipid nanoparticles exhibits enhanced targeting effect against colorectal cancer: A dual-targeted approach. Int J Biol Macromol 2020;151:830-44. 10. Borges A, de Freitas V, Mateus N, Fernandes I, Oliveira J. Solid lipid nanoparticles as carriers of natural phenolic compounds. Antioxidants 2020;9:998. 11. Pinheiro RG, Granja A, Loureiro JA, Pereira MC, Pinheiro M, Neves AR, et al. Quercetin lipid nanoparticles functionalized with transferrin for Alzheimer’s disease. Eur J Pharm Sci 2020;148:105314. 12. Vijayakumar A, Baskaran R, Jang YS, Oh SH, Yoo BK. Quercetin-loaded solid lipid nanoparticle dispersion with improved physicochemical properties and cellular uptake. AAPS PharmSciTech 2017;18:875-83. 13. Talarico L, Consumi M, Leone G, Tamasi G, Magnani A. Solid lipid nanoparticles produced via a coacervation method as promising carriers for controlled release of quercetin. Molecules 2021;26:2694.</References> </References> </Journal> </Article> </ArticleSet>